Stent
NPPA allows differential price for Meril's biodegradable cardiac stent
The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent
 "NPPA allows differential price for Meril's biodegradable cardiac stent")
Meet on stent price cap
Meanwhile, other state drug regulators have also been asked to monitor the prices
 "Meet on stent price cap")
Corporate hospitals making 'unethical, criminal' profits, alleges ADEH
ADEH questions the claims of the corporate hospitals that the imported stents
Stents get cheaper but hospitals might raise other costs
Patients can call NPPA helpline to complain about overcharging
 "Stents get cheaper but hospitals might raise other costs")
Hospitals face regulator ire over stents
Are price caps a long-term cure to the malady, asks Subir Roy
Complaints against two hospitals for stent overcharging: NPPA
NPPA said it had issued show-cause notices to some hospitals over pricing of stents
 "Complaints against two hospitals for stent overcharging: NPPA")
Stent prices reduced 85%, industry says cap overkill
A stent is a mesh tube placed in arteries with a view to improve the blood flow to the heart
Stent prices to be fixed in 10-15 days: Ananth Kumar
NPPA has asked manufacturers and marketers of the medical device to disclose detailed pricing data
 "Stent prices to be fixed in 10-15 days: Ananth Kumar")
Wide gap between stent MRP and manufacturing cost
While multinational's dissolvable stent is sold at Rs 2 lakh, its import price is Rs 42,125
Govt mulls setting CGHS price of stent as cap under NLEM
NPPA also proposes a 10% hike in stent prices if the CGHS model is adopted
Stent manufacturers upset over new order, say patients will suffer
Government has notified drug-eluting stents and bio-degradable stents in the same category
 "Stent manufacturers upset over new order, say patients will suffer")
Domestic stent maker SMT fights perception with new trial
Move comes at a time when MNCs are advocating differential pricing under NLEM
Talks with Centre on price regulation of stents positive: NATHEALTH
Stakeholders moot steps to classify drug-eluting stent through a scoring matrix
MNCs, domestic firms at odds over stent pricing
MNCs say any special price for stents should be granted on clinical proof of the products being superior
